medigraphic.com
ISSN 1405-0315 (Print)

2016, Number Esp

<< Back Next >>

Rev Mex Enf Cardiol 2016; 24 (Esp)

Effect of blood conservation strategies on the transfusion for patients with extracorporeal circulation

Arrieta AG, Ramírez VYE, Martínez JM, Páez CJJ, Cadena-Estrada JC

Language: Spanish
References: 38
Page: 5-11
PDF size: 218.71 Kb.


ABSTRACT

Background: Patients undergoing cardiac surgery are eligible to receive multiple blood transfusions counterparts for reasons such as bleeding; the development of blood conservation strategies (BCS) has protected the patient and limit the risk of infectious, immunologic and inflammatory diseases. Objective: To analyze the effect of blood conservation strategies on blood transfusion in patients undergoing cardiac surgery with cardiopulmonary bypass. Material and methods: Non-experimental, exploratory and transversal study. Probabilistic sample (n = 105) included adult and pediatric patients undergoing cardiopulmonary surgery with extracorporeal circulation (ECC) using the BCS. Data collection with charter expressly demographic, blood transfusion and variables, ECC, BCS. Data analyzed using frequencies, percentages, measures of central tendency and dispersion; and Pearson test, Mann Whitney and Student t; significance p ‹ 0.05. Results: A prevalence of valvular heart disease (42%), corrective surgeries (98%), blood type O+. 120,511 ml blood was recovered 1,161 ml per patient. ECC time related to transfused blood volume (r = 0.318, p = 0.000). BCS largest number in corrective surgery (Z = 2467, p = 0.014) in patients with previous surgeries increased volume (t = 2.072, p = 0.039), amount of blood transfused during ECC is recovered is greater in the pump centrifuge (t = 4,022, p = 0.000), but no sex differences (t = 1.488, p = 0.137). Hemoglobin and hematocrit before and after ECC was similar (p › 0.05). Conclusions: The BCS is an excellent choice for use to avoid homologous transfusion, and who manage to recover a large amount of autologous, enhancing its benefits.


REFERENCES

  1. Vaccaro CA, Vaccarezza H, Giuliano JF, Peralta NC, Rossi GL, Mentz R y cols. El área de superficie corporal: un factor predictor de conversión en cirugía colorrectal laparoscópica. Rev Argent Cir. 2012; 103(4/6): 62-70.

  2. Medina JR. Enfermedades infecciosas transmitidas por transfusión. Panorama internacional y en México. Gaceta Médica de México. 2014; 150: 78-83.

  3. Ferraris VA, Brown JR, Despotis GJ, Hammon JW, Reece TB, Saha SP et al. 2011 Update to the society of thoracic surgeons and the society of cardiovascular anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg. 2011; 91: 944-982.

  4. Alghamdi AA, Albanna MJ, Guru V, Brister SJ. Does the use of erythropoietin reduce the risk of exposure to allogeneic blood transfusion in cardiac surgery? A systematic review and meta-analysis. J Card Surg. 2006; 21(3): 320-326.

  5. Paiva P, Ferreira E, Antunes M. Bloodless open heart surgery: simple and safe. Rev Port Cardiol. 2005; 24(5): 647-654.

  6. Carless PA, Henry DA, Moxey AJ, O’Connell DL, Brown T, Fergusson DA. Rescate celular para disminuir la transfusión perioperatoria de sangre alogénica (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2008, Número 4. Oxford: Update Software Ltd. Disponible en: http://www.update-software.com.

  7. Reyes G, Prieto M, Alvarez P, Orts M, Bustamante J, Santos G et al. Cell saving systems do not reduce the need of transfusion in low-risk patients undergoing cardiac surgery. Interact Cardiovasc Thorac Surg. 2011; 12(2): 189-193.

  8. Gomar C, Mata M, Pomar J. Fisiopatología y técnicas de circulación extracorpórea. Función renal y técnicas de apoyo durante la circulación extracorpórea. Barcelona: Asociación Española de Perfusionistas. 2012, 222-292.

  9. Jiménez JCE. Recomendaciones medicoquirúrgicas para disminuir el uso y pérdida de derivados sanguíneos. Rev Colomb Cir. 2005; 20(2): 105-117.

  10. Moskowitz DM, Klein JJ, Shander A, Perelman SI, McMurtry KA, Cousineau KM et al. Use of the hemobag for modified ultrafiltration in a Jehovah’s Witness patient undergoing cardiac surgery. J Extra Corpor Technol. 2006; 38: 265-270.

  11. Lawrence T, Goodnaough A. Donación de sangre. Clínicas anestesiológicas de Norteamérica. 2005; 23(2): 263-270.

  12. Sosa-García J, Carrillo-Esper R, Díaz-Franco S. Evidencia actual en el uso de hemoderivados en el perioperatorio. Revista Mexicana de Anestesiología. 2014; 37(1): S121-S123.

  13. Ferraris VA, Ferraris SP, Saha SP, Hessel II EA, Haan CK, Royston BD et al. Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg. 2007; 83(5): S27-S86.

  14. Palacios RX, Castro JA, Meza JR, Camilo JJ, Quintero OA. Transfusiones en cirugía cardiaca. Rev Colomb Anestesiol. 2007; 35: 4.

  15. Souza HJBd, Moitinho RF. Strategies to reduce the use of blood components in cardiovascular surgery. Rev Bras Cir Cardiovascular. 2008; 23(1): 53-59.

  16. Guyan W, Bainbridge D, Martin J, Cheng D. The efficacy of an intraoperative cell saver during cardiac surgery: a meta-analysis of randomized trials. Anesth Analg. 2009; 109(2): 320-330.

  17. Molina-Méndez FJ, Luna-Ortíz P, Lespron-Robles MdC, González-Chon O, Ruiz-Durón A, Fernández-Rivera B y cols. Hemofiltración en cirugía cardiaca. Rev Mex Anestesiol. 1997; 20(1): 26-31.

  18. Chalegre ST, Salerno PR, Salerno LMVdO, Melo ARdS, Pinheiro AC, Frazão CdS et al. Vacuum-assisted venous drainage in cardiopulmonary bypass and need of blood transfusion: experience of service. Rev Bras Cir Cardiovasc. 2011; 26(1): 122-127.

  19. Hidalgo Menéndez PA y cols. Efectos de la hemodilución normovolémica con autodonación de bajo volumen sobre varios parámetros hematológicos en la cirugía cardiovascular con circulación extracorpórea. Cor Salud. 2011; 3: 124-133.

  20. Ye L, Lin R, Fan Y, Yang L, Hu J, Shu Q. Effects of circuit residual volume salvage reinfusion on the postoperative clinical outcome for pediatric patients undergoing cardiac surgery. Pediatr Cardiol. 2013; 34(5): 1088-1093.

  21. Llanes Echeverría JR. Soluciones cristaloides y coloides, como sustitutas de la sangre en el cebado del circuito extracorpóreo durante la cirugía cardiovascular. Rev Cubana Cir. 2002; 41: 42-46.

  22. México DODlF. Ley General de Salud [Internet]. Diario Oficial de la Federación 2012; 2014 [Citado 02 de Octubre 2014]; Disponible en: http//www.salud.gob.mx/unidades/cdi/nom/compi/rlgs.html

  23. Brand VK y cols. In. Colomer MF PG. ¿Vigencia del Código de Nüremberg después de cincuenta años?: Cuad Bioética; 1999 [Citado 02 de octubre 2014]; Disponible en: http://aebioética.org/revistas/1999/1/37/07-2bioética-37.pdf

  24. Enfermería. CId. Código de Ética para las Enfermeras y Enfermeros de México Secretaría de Salud México; 2001.

  25. Arrieta AG. Intervenciones para conservar la sangre en cirugía cardiaca con circulación extracorpórea. Rev Mex Enferm Cardiol. 2012; 20(1): 17-20.

  26. Vonk AB, Muntajit W, Bhagirath P, van Barneveld LJ, Romijn JW, de Vroege R et al. Residual blood processing by centrifugation, cell salvage or ultrafiltration in cardiac surgery: effects on clinical hemostatic and ex-vivo rheological parameters. Blood Coagul Fibrinolysis. 2012; 23(7): 622-628.

  27. Silva LL, Andres AJ, Senger R, Stuermer R, Godoy MC, Correa EF et al. Impact of autologous blood transfusion on the use of pack of red blood cells in coronary artery bypass grafting surgery. Rev Bras Cir Cardiovasc. 2013; 28(2): 183-189.

  28. Campbell J, Holland C, Richens D, Skinner H. Impact of cell salvage during cardiac surgery on the thrombelastomeric coagulation profile: a pilot study. Perfusion. 2012; 27(3): 221-224. Epub 2011 Dec 20.

  29. Almeida RM, Leitão L. The use of cell saver system in cardiac surgery with cardiopulmonary byass. Rev Bras Cir Cardiovasc. 2013; 28(1): 76-82.

  30. Arévalo-Espinoza S, Izaguirre-Ávila R, Herrera-Alarcón V, Cerón-Díaz U, Bucio-Reta E, Ruiz-Goytortua M. Hemorragia mayor de lo habitual. Arch Cardiol Mex. 2011; 81(Supl. 1): 24-29.

  31. Moreno-González A, Martínez-Ramírez L, Flores-Figueroa F, Cueto-Robledo G, Antonio-de la Viña M, Baranda-Tova FM. Cuidados posoperatorios del paciente no complicado. Arch Cardiol Mex. 2011; 81(Supl. 2): 16-23.

  32. Zakkar M, Guida G, Angelini GD. Modified ultrafiltration in adult patients undergoing cardiac surgery. Interact Cardiovasc Thorac Surg. 2015; 20(3): 415-421. Epub 2014 Nov 25.

  33. Ziyaeifard M, Alizadehasl A, Massoumi G. Modified ultrafiltration during cardiopulmonary bypass and postoperative course of pediatric cardiac surgery. Res Cardiovasc Med. 2014; 3(2): e17830. Epub 2014 Apr 1

  34. Chuquiure Valenzuela E. Evaluación del riesgo hemorrágico en cirugía cardiaca. Anest Cardiov. 2008; 31(S 1): S121-S126.

  35. Izaguirre R. Manual de Medicina transfusional. México: Instituto Nacional de Cardiología Ignacio Chávez. 1993.

  36. González AO, Hidalgo MPA. Técnicas actuales para la cirugía cardiovascular sin utilizar componentes sanguíneos. Rev Cuba Anestesiol Reanim. 2007; 6(1): 44-65.

  37. Robles MdCL, Méndez FJM. Terapia anticoagulante en la circulación extracorpórea. Arch Cardiol Mex. 2007; 4: 185-193.

  38. Koch CG, Li L, Duncan AI, Mihaljevic T, Cosgrove DM, Loop FD et al. Morbidity and mortality risk associated with red blood cell and blood component transfusion in isolated coronary artery bypass grafting. Crit Care Med. 2006; 34: 1608-1616.




2020     |     www.medigraphic.com